top of page

Search Results

Results found for "assay development"

  • Antibodies That Don’t Block, They Activate: A New Angle on Autoimmunity and GPCRs

    The Tools to Detect Them Using the multiplexed GPCR library and Luminex assay , researchers can now: GPCR ecosystem , multiplex assays

  • Science Needs Rigor, But Also Joy

    Four hundred plates of assays, concentration-response curves, and mutagenesis screens are standard. _______ Keyword Cloud: GPCR scientist network, GPCR training program, mentorship in science, GTPÎłS assay

  • From Snapshots to Predictions: Why Mechanism of Action Matters

    Corner you'll learn how model-based thinking helps you determine a drug’s mechanism of action and turn assay most difficult calls in pharmacology happen when two different mechanisms look identical in a single assay Without a framework, this looks like an assay error. In HIV entry studies, purified gp120 was too expensive for routine assays. A Case That Seemed Impossible In one real program, a compound produced four completely different assay

  • How Fast Does a Drug Work?

    Every day spent misunderstanding what your assays are truly showing you can lead to costly missteps—wasted Kenakin’s kinetic insights help you translate assay readouts into actionable knowledge that keeps your ’t Let Outdated Models Slow Your Next Program The analytical tools that shaped traditional affinity assays You’ll gain clarity that accelerates your path from discovery to clinic: Know when your assays truly

  • From GPCR Data Chaos to Decisive Action

    I call it the Lego Bucket Problem : You’ve got CRO output, internal assay data, maybe even some promising arrives too fast and too fragmented CROs deliver output without clear integration Teams chase the wrong assays Here’s what I bring: Biology-First Strategy I’ve designed GPCR assays, led collaborations across research

  • GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures

    They design assays differently. They interpret deviations differently. Dual-assay strategies (high and low sensitivity) are essential, not optional. Assay Volume Control: Classification Through Contrast Sensitivity doesn’t merely change the size of the ligands from a single system: The same molecule can occupy different mechanistic categories across assay requires understanding where the ligand sits on the operational curve—not just where it sits in one assay

  • The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts

    pipes instrument outputs into a central hub — where QC, analysis, consumption and consolidation across assays GPCR Drug Discovery The only way out for GPCR drug discovery programs isn’t more people or shinier assays The Hidden Costs of Poor Drug Discovery Data Management Stop pretending more hires or new assays will

  • Mapping Motion: Intermediate States, Deorphanization & Discovery

    visualizing intermediate states with triple-color FRET, and deorphanizing targets using the new G(z)ESTY assay G(z)ESTY as an optimized cell-based assay for initial steps in GPCR deorphanization .  

  • đź“° GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!

    Dates:  October 3 to 31, 2024 What You’ll Master during the five sessions: Utilizing new cellular assays GPCRs and mRNA antigens enable drug discovery and development Mapping GPCR-RAMP complexes with MolBoolean Screening GPR75 Modulators Using Medium-Throughput Reporter Gene Assay GPCR Therapeutics Optimizes the Joint Development of New Drugs Using Intralinks’ Virtual Data Room   GPCR Events, Meetings, and Webinars 4th Transatlantic ECI GPCR Symposium September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays

  • Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!

    Elements of a comprehensive and effective GPCR discovery Master advanced applications: Using new cellular assays codon-optimized clytin II gene in Chinese hamster ovary-K1 cells and its use in the G-protein-coupled receptor assays GPCR Events, Meetings, and Webinars September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays

  • Why “Displacement” Misleads You: Allosteric Binding Demystified

    If you’re applying orthosteric logic to modulator-driven systems, you’re likely misreading your assays—and Binding assays  report on one set of receptor states. Functional assays  track another.

  • Why Intracellular Drugs May Hold the Key to GPCR Therapeutics

    the cell ✅ Tools for evaluating scaffold permeability using modern, cost-effective pharmacokinetic assays In a traditional assay, they look the same. But in vivo? The good news: we now have reliable, low-cost assays to find out —Kenakin walks through the essential

  • Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells

    Ligand-directed labelling strategies  are a newly developed way to attach a fluorescent tag to a GPCR other ligands and are very interesting in TR-FRET (Time-Resolved Förster Energy Resonance Transfer) assays A Robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.

  • Allosteric Binding Data Interpretation in Complex Receptor Systems

    We are not measuring the same receptor in these assays. The consequences for assay interpretation are direct: Observed affinity changes reflect altered receptor ligand inadequacy In translational settings, this explains why compounds behave differently across assay For pharmacologists refining assay interpretation, for teams navigating conflicting data, and for leaders

  • New Podcast, Sweet Structures & $2.2B GPCR Moves

    membrane-driven modulation of mGluR2, and a big headline, Novo Nordisk’s $2.2B deal with Septerna to develop In Episode 166, Ben Clements dives into opioid pharmacology, GPCR-targeted PAMs, and how old-school assays

  • Is Your Agonist Really “Working”—Or Are You Just Seeing What Your System Allows?

    analogies (think batteries and balance scales), Terry reveals why different tissues—and even different assays—can

  • Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024

    Embark on this week’s thrilling updates in GPCR research, learning opportunities, and industry developments Topics: New cellular assays, real-time kinetics, and unique GPCR behaviors. Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work  in a developing -3, 2024 Join leading scientists to investigate the most recent advancements in GPCR-targeted drug development 4th Transatlantic ECI GPCR Symposium September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays

  • A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology in...

    activation state of G protein-coupled receptors are a useful addition to the molecular pharmacology assay the detection of both (partial) agonism and inverse agonism on living cells in a microplate reader assay better correlated with binding affinity values that were measured in radioligand competition binding assays biosensor in membranes might be a ready-to-use, high-throughput alternative for radioligand binding assays that in addition can also detect ligand efficacies with comparable values as the intact cell assay."

  • Pharmacology Isn't What You Think—It's So Much More

    Whether you're heading into your first assay or trying to make sense of inconsistent data, Terry gives

  • How Schild Analysis Protects Your Conclusions in GPCR Research

    Terry’s Corner: Schild Analysis — Why It Matters Most assays show a clean rightward shift and we assume Who should listen Researchers navigating complex datasets, balancing innovation with assay rigor, or Aside from his vast experience in drug development, not to mention his extensive publication record,

  • CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma via...

    8 and colon formation, and cell migration and invasion were detected by wound healing and transwell assays Western blot and RT–qPCR assays were carried out to measure the downstream factors of the interaction The effect of CCL25 on the development of SACC in vivo was examined by a xenograft tumor model in nude

  • Breaking the Myth of High and Low Affinity Sites

    information from binding experiments that advance your work efficiently ✅ Clarity that helps you move from assay Move Faster, Smarter, and with Confidence   When you understand what your assays are truly showing you

  • From Failed Experiments to Predictive GPCR Models

    Watch Episode 175 From failed assays to breakthroughs in GPCR modeling , Dr. Rather than focusing solely on explaining receptor behavior post hoc, his group began developing workflows Carlsson notes that it’s easier to find pharmacologists to run assays than it is to persuade chemists Trainees must learn how to interpret assay data, understand pharmacological context, and communicate

  • How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program

    Learn how his research aims to develop models that can distinguish between active and inactive ligands

  • Profiling Immune Cell and Platelet Transcriptomes

    current study found that 133 of these receptors were also detected, highlighting the robustness of the assay previous study not detected in the current analysis, suggesting that variations in cell preparation and assay

  • Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered

    They employed a series of phospho-mimicking mutants and assays such as linear ion trap mass spectrometry , BRET, pull down, and transwell cell migration assays to investigate the effects of these modifications This knowledge could inform the development of therapeutic strategies aimed at targeting specific phosphorylation

  • Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right

    to replace inference with models that disentangle mechanism—so your next go/no-go, dose range, and assay Engineer assays on purpose:  Set ranges, controls, and system sensitivity to surface mechanism—before Assay flexibility:  Combine self-labeling tags with quantitative readouts (e.g., TR-FRET) to expand mechanism

  • đź“° GPCR Weekly News, November 20 to 26, 2023

    as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays Gene Therapy Suite Avantor® Expands Cellular Science Offerings with Multispan Cell Engineering and Assay AI 2023 Workshop Salipro Biotech AB Celebrates Milestones in CryoEM Structures and In Vitro Binding Assays Genentech and NVIDIA Enter Into Strategic AI Research Collaboration to Accelerate Drug Discovery and Development

  • Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did

    While others pivoted, Sokhom went deeper: refining assays, exploring signaling bias, and building a robust

  • Single-molecule counting applied to the study of GPCR oligomerization

    proteins that participate in many vital physiological functions making them a popular target for drug development for the role of oligomerization in receptor signaling came from ensemble biochemical and biophysical assays Here, we review recent developments in single-molecule counting with a focus on photobleaching step counting

bottom of page